Cycurion (NASDAQ: CYCU) sets Aug. 20 Panel hearing as Nasdaq listing review continues
Rhea-AI Filing Summary
Cycurion, Inc. reported an update on its Nasdaq listing compliance process. The company confirmed that its hearing before the Nasdaq Hearings Panel is scheduled for August 20, 2026 at 10:00 a.m. Eastern Time. Until the Panel issues a final written decision, Cycurion’s timely request for a hearing has stayed the delisting action to the extent permitted by Nasdaq rules, and the company’s common stock continues to trade on the Nasdaq Capital Market under the symbol CYCU. The company emphasized that it does not expect a final written decision on the hearing date itself and that the timing and outcome of the decision rest solely with the Panel. Cycurion stated it will promptly disclose the Panel’s decision and any other material developments related to its listing status.
Positive
- None.
Negative
- Nasdaq listing at risk pending Panel decision: the company highlights that a Nasdaq Hearings Panel will rule on its continued listing, and notes the possibility that the Panel may determine to delist its securities.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Nasdaq hearing date and time: August 20, 2026 at 10:00 a.m. Eastern Time
Warrant exercise price: $345.00 per share
Common stock trading venue: Nasdaq Capital Market
3 metrics
Nasdaq hearing date and time
August 20, 2026 at 10:00 a.m. Eastern Time
Scheduled hearing before the Nasdaq Hearings Panel regarding continued listing
Warrant exercise price
$345.00 per share
Each redeemable warrant exercisable for one share of common stock
Common stock trading venue
Nasdaq Capital Market
CYCU common stock continues to trade pending Panel decision
Key Terms
Nasdaq Hearings Panel, delisting action, Emerging growth company, forward-looking statements
4 terms
Nasdaq Hearings Panel regulatory
"update regarding its pending hearing before the Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
delisting action regulatory
"timely hearing request has stayed the delisting action"
Delisting action is the removal of a company’s shares from a public stock exchange so they can no longer trade on that market. Think of it as being forced out of a big marketplace into a much smaller one or off the market entirely; this matters to investors because it usually reduces liquidity, makes shares harder to buy or sell, can sharply affect price, and signals regulatory, financial, or operational problems that increase risk.
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
forward-looking statements regulatory
"This press release contains statements that are forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Cycurion (CYCU) disclose about its Nasdaq hearing?
Cycurion disclosed that its Nasdaq Hearings Panel session is scheduled for August 20, 2026 at 10:00 a.m. ET. This hearing will address the company’s continued listing status on the Nasdaq Capital Market.
Is Cycurion’s (CYCU) stock currently delisted from Nasdaq?
No. Cycurion’s common stock continues to trade on the Nasdaq Capital Market under the symbol CYCU. A timely hearing request has stayed the delisting action pending the Panel’s final written decision.
When will Cycurion (CYCU) receive a decision from the Nasdaq Panel?
Cycurion stated it does not expect a final decision on the hearing date. The timing of the Panel’s written decision is determined solely by the Panel and has not been specified.
Could Cycurion (CYCU) be delisted from Nasdaq after the hearing?
Yes, the company notes the possibility that the Panel may determine to delist its securities. It also cites risks around satisfying any conditions the Panel might impose to maintain Nasdaq listing.
What securities of Cycurion (CYCU) are listed and what are its warrants’ terms?
Cycurion lists common stock (symbol CYCU) and redeemable warrants (symbol CYCUW). Each warrant is exercisable for one share of common stock at an exercise price of $345.00 per share.
How will Cycurion (CYCU) update investors on the Nasdaq listing process?
Cycurion stated it will promptly disclose the Panel’s decision and any other material developments related to its Nasdaq listing, in line with its applicable disclosure obligations.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 7, 2026
(Exact Name of Registrant as Specified in Its Charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: (888 ) 341-6680
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 8.01 Other Events.
On August 7, 2026, the Company issued a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
(d)Exhibits:
| Exhibit No. | Description | |||||||
| 99.1 | Press Release dated August 7, 2026 | |||||||
| 104 | Inline XBRL for the cover page of this Current Report on Form 8-K | |||||||
2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CYCURION, INC. | ||||||||||||||
| Date: | August 12, 2026 | By: | /s/ L. Kevin Kelly | |||||||||||
| Name: | L. Kevin Kelly | |||||||||||||
| Title: | Chief Executive Officer | |||||||||||||
3
Exhibit 99.1
Cycurion Confirms August 20 Nasdaq Hearing Date; Common Stock Continues Trading on Nasdaq
August 7, 2026
MCLEAN, Va., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading AI-driven, tech-enabled cybersecurity solutions provider, today provided an update regarding its pending hearing before the Nasdaq Hearings Panel (the “Panel”).
The Company’s hearing has not yet occurred and is scheduled for August 20, 2026, at 10:00 a.m. Eastern Time. Cycurion’s common stock has not been delisted and continues to trade on the Nasdaq Capital Market under the symbol “CYCU.”
The Company’s timely hearing request has stayed the delisting action, to the extent permitted by Nasdaq Listing Rules, pending the Panel’s final written decision.
The hearing is a proceeding before the Panel, and the Company does not expect to receive a final written decision on the date of the hearing. The timing of the Panel’s final written decision is determined solely by the Panel. Cycurion will promptly disclose the Panel’s decision and any other material developments, as appropriate and in accordance with applicable disclosure obligations.
“We are providing this clarification in response to shareholder inquiries,” said Kevin Kelly, Chairman and Chief Executive Officer of Cycurion. “The hearing has not yet occurred, and Cycurion remains focused on executing its business plan and addressing the Nasdaq process. We will keep investors informed of material developments as they occur, and we appreciate the continued support of our shareholders.”
About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity and AI solutions, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. More info: www.cycurion.com.
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, the scheduling and timing of the Company’s hearing before the Nasdaq Hearings Panel; the anticipated timing of the Panel’s decision; the outcome of that hearing; the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements; the continued listing and trading of the Company’s common stock; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions intended to identify such forward-looking statements. All forward-looking
statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcome and timing of the Panel’s decision, which is outside the Company’s control; the possibility that the Panel may determine to delist the Company’s securities; the Company’s ability to satisfy any conditions imposed by the Panel; any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com
Cycurion Media Relations:
(888) 341-6680
media@cycurion.com
2